Sanara MedTech Inc. (SMTI): Price and Financial Metrics


Sanara MedTech Inc. (SMTI): $36.86

-0.54 (-1.44%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SMTI POWR Grades

  • Sentiment is the dimension where SMTI ranks best; there it ranks ahead of 96.9% of US stocks.
  • SMTI's strongest trending metric is Momentum; it's been moving down over the last 179 days.
  • SMTI ranks lowest in Momentum; there it ranks in the 10th percentile.

SMTI Stock Summary

  • The ratio of debt to operating expenses for SANARA MEDTECH INC is higher than it is for about only 6.49% of US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, SANARA MEDTECH INC is reporting a growth rate of 179.8%; that's higher than 91.04% of US stocks.
  • As for revenue growth, note that SMTI's revenue has grown 71.51% over the past 12 months; that beats the revenue growth of 88.05% of US companies in our set.
  • Stocks that are quantitatively similar to SMTI, based on their financial statements, market capitalization, and price volatility, are NAOV, CDXC, OTLY, VEEE, and EVER.
  • SMTI's SEC filings can be seen here. And to visit SANARA MEDTECH INC's official web site, go to www.wndm.com.

SMTI Valuation Summary

  • In comparison to the median Healthcare stock, SMTI's price/sales ratio is 305% higher, now standing at 8.1.
  • SMTI's price/sales ratio has moved up 8.1 over the prior 243 months.

Below are key valuation metrics over time for SMTI.

Stock Date P/S P/B P/E EV/EBIT
SMTI 2022-11-25 8.1 6.7 -26.6 -22.7
SMTI 2022-11-23 8.1 6.7 -26.6 -22.7
SMTI 2022-11-22 8.1 6.7 -26.6 -22.7
SMTI 2022-11-21 8.2 6.7 -26.9 -23.0
SMTI 2022-11-18 8.3 6.8 -27.3 -23.3
SMTI 2022-11-17 8.4 7.0 -27.7 -23.7

SMTI Growth Metrics

    Its 4 year cash and equivalents growth rate is now at 382.61%.
  • Its 5 year net cashflow from operations growth rate is now at -1019.57%.
  • The 2 year price growth rate now stands at 89.79%.
SMTI's revenue has moved up $30,089,508 over the prior 52 months.

The table below shows SMTI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 37.55998 -6.694212 -11.39348
2022-06-30 30.33935 -6.485426 -11.94339
2022-03-31 26.94571 -5.6654 -9.869494
2021-12-31 24.14392 -4.814526 -7.921914
2021-09-30 21.89965 -3.621237 -4.620099
2021-06-30 20.38203 -2.898222 -3.746955

SMTI Stock Price Chart Interactive Chart >

Price chart for SMTI

SMTI Price/Volume Stats

Current price $36.86 52-week high $39.99
Prev. close $37.40 52-week low $17.41
Day low $36.50 Volume 15,900
Day high $39.00 Avg. volume 18,781
50-day MA $31.80 Dividend yield N/A
200-day MA $27.24 Market Cap 306.09M

Sanara MedTech Inc. (SMTI) Company Bio


Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.


SMTI Latest News Stream


Event/Time News Detail
Loading, please wait...

SMTI Latest Social Stream


Loading social stream, please wait...

View Full SMTI Social Stream

Latest SMTI News From Around the Web

Below are the latest news stories about SANARA MEDTECH INC that investors may wish to consider to help them evaluate SMTI as an investment opportunity.

Sanara MedTech to Participate in Two Upcoming Healthcare Conferences

FORT WORTH, TX, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today that Zach Fleming, the Company’s Chief Executive Officer, will present at the Piper Sandler 34th Annual Healthcare Conference in New York, New York on Wednesday, November 30, 2022 at 12:30 p.m. ET and will participate in a panel discu

Yahoo | November 21, 2022

Sanara MedTech Inc. Announces Third Quarter 2022 Results

FORT WORTH, TX, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today its strategic, operational and financial results for the quarter ended September 30, 2022. Zach Fleming, Sanara's CEO, stated, “The third quarter of 2022 was another revenue record for S

Yahoo | November 14, 2022

Sanara MedTech and InfuSystem Announce Wound Therapy Partnership

FORT WORTH, TX, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI) and InfuSystem Holdings, Inc. (“InfuSystem”) (NYSE American: INFU) announced today the establishment of a partnership, SI Wound Care, LLC (“SI Wound Care”), focused on delivering a complete wound care solution targeted at improving patient outcomes, lowering the cost of care, and increasing patient and provider satisfaction. The partnership is expected to enable Inf

Yahoo | November 3, 2022

InfuSystem and Sanara MedTech Announce Wound Therapy Partnership

ROCHESTER HILLS, Mich., November 03, 2022--InfuSystem and Sanara MedTech Announce Wound Therapy Partnership

Yahoo | November 3, 2022

Sanara MedTech Inc. Announces Third Quarter 2022 Earnings Release and Conference Call Dates

FORT WORTH, TX, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving patient outcomes, announced today details for the release of its results for the quarter ended September 30, 2022. Sanara will issue its earnings release on Monday, November 14, 2022, and will host a conference call on T

Yahoo | November 1, 2022

Read More 'SMTI' Stories Here

SMTI Price Returns

1-mo 22.87%
3-mo 17.20%
6-mo 79.80%
1-year 34.04%
3-year 332.63%
5-year N/A
YTD 24.74%
2021 -40.78%
2020 209.94%
2019 392.35%
2018 -45.50%
2017 58.31%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6559 seconds.